Full vs empty bladder for pelvic radiation
Part of Cancer clinical trials.
This trial is comparing two ways to prepare for pelvic radiation therapy: either with a full bladder or an empty bladder. The goal is to see which method works better for protecting healthy organs and reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are getting radiation therapy to your pelvis for a cancer (such as bladder, prostate, rectum, cervix, or uterus) with the goal of a cure.
- The cancer has not spread into your bladder.
- You have not had radiation therapy to the pelvis before.
- You do not have Crohn's disease, scleroderma, or uncontrolled lupus (conditions that increase the risk of radiation side effects).
- If you can become pregnant, you agree to use effective birth control for at least 1 month before and during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of giving radiation to the prostate and pelvic lymph nodes. It also tests two different instructions for how full your bladder should be during treatment. The goal is to see which approach works better and is easier for patients.
This trial tests if a shorter course of radiation therapy works as well as the usual longer course for people with bladder cancer who are also receiving standard chemotherapy. The goal is to see if shorter treatment can reduce side effects while still being effective.
This study tests whether a shorter, more focused radiation plan given at the same time as chemotherapy can control muscle-invasive bladder cancer while keeping the bladder. You may be offered bladder-preserving treatment if your cancer stage and health conditions fit the study rules.
This trial tests whether adding radiation therapy to immunotherapy after bladder removal surgery can help prevent cancer from coming back. It's for people with advanced bladder cancer who have already started immunotherapy.
This trial tests a new online adaptive radiotherapy technique for bladder cancer that adjusts the radiation plan daily based on changes in the bladder. It aims to improve treatment accuracy and reduce side effects.
This trial tests whether radiation therapy can help people whose bladder cancer (specifically carcinoma in situ) did not get better with BCG treatment and who are not having their bladder removed. It aims to offer a less invasive option for controlling the cancer.
Hear when a new Pelvic Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.